Clinical Trials in Boston

Showing 9001-9020 of 13,548 trials

Tetra-O-Methyl Nordihydroguaiaretic Acid in Treating Patients With Recurrent High-Grade Glioma

NCT00404248

RATIONALE: Drugs used in chemotherapy, such as tetra-O-methyl nordihydroguaiaretic acid (EM-1421), work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. PURPOSE: This phase I/II trial is studying the side effects and best dose of EM-1421 and to see how well it works in treating patients with recurrent high-grade glioma.

Brain and Central Nervous System Tumors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins35 participantsStarted Jan 2007

Birmingham, Alabama, United States • Tampa, Florida, United States • Atlanta, Georgia, United States +6 more locations

COMPLETED< 1 mile

Multicenter Benchmarking of Functional and Psychosocial Outcomes of Pediatric Burn Survivors

NCT00239668

The purpose of this study is to establish an expected recovery trajectory (recovery model) in terms of physical and psychological function of the pediatric burn patient.

Burn

Massachusetts General Hospital3,000 participantsStarted Mar 2000

Sacramento, California, United States • Boston, Massachusetts, United States • Cincinnati, Ohio, United States +1 more locations

Tetra-O-Methyl Nordihydroguaiaretic Acid in Treating Patients With Recurrent High-Grade Glioma

Multicenter Benchmarking of Functional and Psychosocial Outcomes of Pediatric Burn Survivors

Find Trials by Condition in Boston

ExAblate UF V2 System for the Treatment of Symptomatic Uterine Fibroids

Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir and Sofosbuvir/Velpatasvir in Adults With Chronic HCV Infection Who Have Not Previously Received Treatment With Direct-Acting Antiviral Therapy

The Effect of 3 Different Models of MNT on DM Control in Overweight Patients With T2DM

Effect of Dairy Consumption on Glycemic Control, Body Weight and Cardiovascular Risk Factors

Effect of Dairy Consumption on Glycemic Control, Body Weight and Cardiovascular Risk in Patients With Type 2 Diabetes

Effect of D-cycloserine Plus Cognitive Behavioral Therapy on People With Social Phobia

Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument

A Trial of SAMe for Treatment-Resistant Bipolar Depression

Long-term Follow-up Study of Subjects Who Completed Clinical Studies 755.1100_FA, 810.1100_FA, or 1064.1100_FA

Machine Learning to Predict Clinical Response to TMS

Efficacy and Safety Evaluation of AN2690 Topical Solution to Treat Onychomycosis of the Toenail

Safety and Efficacy of Polymyxin B Hemoperfusion (PMX) for Septic Shock

A Study to Assess the Safety of a Potential New Drug in Comparison to the Standard Practice of Dosing With Warfarin for Non-valvular Atrial Fibrillation

A Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus Erythematosus

Irrigated Ablation System Evaluation for Atrial Fibrillation (AF)

Assessment of Diagnostic Accuracy and Performance of Digital Breast Tomosynthesis Compared to Mammography (ADAPT)

Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).

VL-2397 Compared to Standard First-Line Treatment for Invasive Aspergillosis (IA) in Adults